All articles by GlobalData Healthcare

1. Twitter round-up: Cardiovascular trends in November2019

   Pharmaceutical Technology lists ten of the most popular tweets in cardiovascular in November 2019, based on data from GlobalData’s Influencer…
   Read More…

   10 Dec
2. Can controlled substances become the new standard of care for psychiatric disorders?

   Disorders such as depression and anxiety have long been treated with drugs that are associated with side effects such as…
   Read More…

   9 Dec
3. Is Big Pharma’s R&D spending spiralling out of control? BMS’s Celgene acquisition suggests yes

   Large pharma companies are investing a disproportionately large amount of annual revenue in research & development (R&D), according to GlobalData’s…
   Read More…

   5 Dec
4. Contract manufacturing in “tremendous” state as growth strains current capacity, CPhI delegates told

   The growth and demand for contract manufacturing services are “tremendous” and contract manufacturing organisations (CMOs) are operating close to capacity,…
   Read More…

   4 Dec
5. Pharma favours cybersecurity and blockchain investment over ‘hyped’ AI, VR and IoT

   Pharma companies are embracing cybersecurity and related technology investments over artificial intelligence (AI), virtual reality (VR) and the Internet of…
   Read More…

   4 Dec
6. Guangdong’s 10-point plan part of southern Chinese pharma industry ‘growth pole’ campaign

   China is a major active pharmaceutical ingredient (API) and intermediates manufacturer for the drug industry around the world, and it…
   Read More…

   3 Dec
7. Setback in the US as SGLT inhibitor empagliflozin fails FDA vote

   Recently a US Food and Drug Administration (FDA) advisory panel recommended against the approval of Eli Lilly/Boehringer Ingelheim’s empagliflozin. This…
   Read More…

   3 Dec
8. Vaccination may be the answer to JAK inhibitor-associated shingles risk, but its safety in RA remains in question

   At the 2019 American College of Rheumatology (ACR)/Association of Rheumatology Professionals (ARP) Annual Meeting, data was presented for members of…
   Read More…

   2 Dec
9. Ervebo roll out asks more questions than it answers

   In November 2019, the European Medical Agency (EMA) approved the first ever Ebola vaccine, Merck’s Ervebo. This followed a positive…
   Read More…

   29 Nov
10. Treatment with some JAK inhibitors linked to increased risk of shingles

    While the degree of JAK inhibitor-associated cardiovascular risk remains ambiguous, it is clear that treatment with JAK inhibitors can increase…
    Read More…

    29 Nov